Levels of symptom burden during chemotherapy for advanced lung cancer: differences between public hospitals and a tertiary cancer center.

@article{Cleeland2011LevelsOS,
  title={Levels of symptom burden during chemotherapy for advanced lung cancer: differences between public hospitals and a tertiary cancer center.},
  author={Charles S. Cleeland and Tito R Mendoza and Xin Shelley Wang and Jeanie F Woodruff and Guadalupe R Palos and Stephen P. Richman and Arlene Nazario and Garrett Rushing Lynch and Kai-Ping Liao and Gary M Mobley and Charles Lu},
  journal={Journal of clinical oncology : official journal of the American Society of Clinical Oncology},
  year={2011},
  volume={29 21},
  pages={2859-65}
}
PURPOSE We compared risk factors for high disease- and treatment-related symptom burden over 15 weeks of therapy in medically underserved patients with advanced non-small-cell lung cancer and in patients treated at a tertiary cancer center. PATIENTS AND METHODS We monitored symptom severity weekly during chemotherapy. Patients were recruited from a tertiary cancer center (n=101) and three public hospitals treating the medically underserved (n=80). We used a composite symptom-severity score… CONTINUE READING
19 Citations
0 References
Similar Papers

Citations

Publications citing this paper.
Showing 1-10 of 19 extracted citations

Similar Papers

Loading similar papers…